APDN - Applied DNA Sciences Inc. (APDN) Q1 2024 Earnings Call Transcript
2024-02-09 13:32:06 ET
Applied DNA Sciences, Inc. (APDN)
Q1 2024 Results Conference Call
February 08, 2024 04:30 PM ET
Company Participants
Sanjay Hurry - Head of IR
Beth Jantzen - Chief Financial Officer
Dr. James Hayward - Chairman, President and CEO
Clay Shorrock - Chief Legal Officer and Head of Business Development
Judy Murrah - Chief Operating Officer
Conference Call Participants
Jason McCarthy - Maxim Group
Dipesh Patel - H.C. Wainwright
Jeffrey Bernstein - Silverberg Bernstein Capital
Presentation
Operator
Good day and welcome to the Applied DNA Sciences Fiscal First Quarter 2024 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded.
I would now like to turn the conference over to Sanjay Hurry, Head of Investor Relations. Please go ahead.
Sanjay Hurry
Thank you, Scott. Good afternoon, everyone, and welcome to Applied DNA's conference call to discuss our first quarter fiscal 2024 financial results. You can access the press release that was issued after market closed today as well as the slide presentation accompanying this call on the Investor Relations section of our corporate website.
Speaking on the call today are Dr. James Hayward, our Chairman, President, and CEO; and Beth Jantzen, our Chief Financial Officer. Clay Shorrock, our Chief Legal Officer and Head of Business Development, and Judy Murrah, our Chief Operating Officer, will also be available to answer questions on the Q&A portion of this call....
Applied DNA Sciences, Inc. (APDN) Q1 2024 Earnings Call Transcript